SCYNEXIS
SCYX
$1.54
Share price
4.76%
Change (1 day)
-49.67%
Change (1 year)
Categories
Operating Margin for SCYNEXIS (SCYX)
Operating Margin as of April 2024 (TTM): -1,223.94%
According to SCYNEXIS's latest financial reports and stock price the company's current Operating Margin is -1,223.94%. At the end of 2021 the company had an Operating Margin of -252.94%.
Operating Margin history for SCYNEXIS from 2013 to 2022
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -252.94% | |
| 2019 | -43,573.55% | 552.97% |
| 2018 | -6,673.15% | -26.09% |
| 2017 | -9,029.18% | -21.71% |
| 2016 | -11,532.30% | 4.55% |
| 2015 | -11,030.74% | 50031.1% |
| 2014 | -22.00% | -80.03% |
| 2013 | -110.19% | 76.61% |
| 2012 | -62.39% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Galmed Pharmaceuticals
GLMD | -479.93% | -60.79% | 🇮🇱 Israel |
 Catalyst Pharmaceuticals CPRX | 48.88% | -103.99% | 🇺🇸 USA |
 Catalent CTLT | 4.60% | -100.38% | 🇺🇸 USA |
 KemPharm KMPH | -400.65% | -67.27% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.